Dr. Shawn Zhang has served as our Senior Vice President of R&D Operations and Ambrx China since April 2021, and previously was Vice President of Research. Dr. Zhang is an established executive in the areas of drug R&D, business development, product sourcing, in-licensing, project management and senior management leadership. Shawn has also demonstrated hands-on and managerial experience in drug target selection and validation, assay development, lead discovery, preclinical and clinical development. Before his appointment, Shawn was the Vice President of Research at HUYA Bioscience International. As a senior management team member, he oversaw new product sourcing, drug evaluation, in-licensing, and research/ development, in a wide range of therapeutic areas including oncology, metabolic diseases, inflammation and companion diagnostics/biomarkers. Prior to that, in Mitsubishi-Tanabe, Shawn established and led multiple drug projects in oncology, immunology and metabolic diseases. Dr. Zhang obtained his Ph.D. in Biochemistry from UCSD/Salk Institute, MS in molecular genetics from Institute of Genetics, Chinese Academy of Science and B.S. in biology from Beijing Normal University.